These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8047833)

  • 1. Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease.
    Hillman AL
    Scand J Gastroenterol Suppl; 1994; 201():98-102. PubMed ID: 8047833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.
    Hillman AL; Bloom BS; Fendrick AM; Schwartz JS
    Arch Intern Med; 1992 Jul; 152(7):1467-72. PubMed ID: 1627026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
    Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia.
    Kaplan-Machlis B; Spiegler GE; Zodet MW; Revicki DA
    Arch Fam Med; 2000 Jul; 9(7):624-30. PubMed ID: 10910310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis.
    Eggleston A; Wigerinck A; Huijghebaert S; Dubois D; Haycox A
    Gut; 1998 Jan; 42(1):13-6. PubMed ID: 9505878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
    Ofman JJ; Yamashita BD; Siddique RM; Larson LR; Willian MK
    Am J Manag Care; 2000 Aug; 6(8):905-16. PubMed ID: 11186502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.
    Bloom BS; Hillman AL; LaMont B; Liss C; Schwartz JS; Stever GJ
    Pharmacoeconomics; 1995 Oct; 8(4):343-9. PubMed ID: 10155675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
    Dettmar PW; Sykes J; Little SL; Bryan J
    Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
    Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
    BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
    Barradell LB; McTavish D
    Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture.
    Stal JM; Gregor JC; Preiksaitis HG; Reynolds RP
    Can J Gastroenterol; 1998; 12(1):43-9. PubMed ID: 9544411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):267-77. PubMed ID: 11950383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term consequences with regard to clinical outcome and cost-effectiveness of episodic treatment with omeprazole or ranitidine for healing of duodenal ulcer.
    Walan A; Eriksson S
    Scand J Gastroenterol Suppl; 1994; 201():91-7. PubMed ID: 8047832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and quality effects of treating erosive oesophagitis. A re-evaluation.
    Bloom BS
    Pharmacoeconomics; 1995 Aug; 8(2):139-46. PubMed ID: 10155608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.
    Havelund T; Laursen LS; Lauritsen K
    Scand J Gastroenterol Suppl; 1994; 201():69-73. PubMed ID: 8047827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.